LA JOLLA, Calif., Dec. 18, 2013 (GLOBE NEWSWIRE) -- EHouse Global, Inc. (OTCBB: EHOS ), (the "Company") ( www.EHouse-Global.com ), an emerging specialty nutraceutical company in the $26 Billion dietary supplement industry, would like to announce the launch of their new product line of 16 different nutritional supplements, under the brand www.NutraLiquids.com , which are all gluten free, and natural.
Based on new consumer trends of gluten sensitive shoppers and more recent medical acknowledgement of the harms of celiac disease, the Company has engineered their new products to serve as a unique offering within the large nutrition and nutraceutical industry. NutraLiquids offers a complete line of nutritional supplements in single-serve pouches with some products also available in 30 day supply, 30 ounce bottles. Their line varies from children's multivitamins and Omega blends to specialty items like sleep enhancement, natural energy, and hangover prevention products.
Identifying a food sensitivity can have a profound impact on one's life. Many people report migraines and foggy mind, stomach and joint aches, dental problems, fatigue and digestive upset on a daily basis, without ever knowing that the cause could be their diets.
Although researchers at the CFCRT are working to develop tests for gluten sensitivity, currently there are no definitive blood tests for the condition. Just as in celiac disease, there is no cure for gluten sensitivity. The only treatment currently available is the gluten-free diet.
Research from the Center for Celiac Research & Treatment (CFCRT) indicates that gluten sensitivity affects approximately 18 million people, which is six percent of the US population.
Scott Corlett, CEO of Ehouse Global, commented:
"Incorporating the gluten-free lifestyle into our product line was a must for our company. With myself and three of my children suffering from various degrees of gluten sensitivity, I know firsthand how difficult it is to find supplements that are gluten-free. Until we reached diagnosis, my family was a very sickly group, but now having been gluten-free for over 4 years, we are all very healthy and active.
"The market we operate in is large with quite a few players, but we feel we have developed an edge with our gluten free naturalist focus all within our unique branding/ packaging. Whenever our products are showcased, whether at tradeshows or sales meetings, they are met with a warm reception of intrigue and interest."
About EHouse Global (EHOS)
EHouse Global is a publicly traded company on the OTCBB Market stock exchange under the ticker symbol EHOS. Headquartered in La Jolla, CA, EHouse Global acquires, develops and sells leading edge consumer oriented products ready for rapid commercialization. Much of its resources are dedicated to research and development in order to provide consumers with quality options while meeting the expectations of its investors. For information about EHouse go to www.ehouse-global.com .
Through our wholly owned subsidiary NutraLiquids LLC, our launch includes 16 different liquid nutritional products in single serving pouches with some products also available in 30 day supply, 30 ounce bottles. Each product is gluten-free, and are loaded with vitamins, nutrients and natural ingredients proven to support each product's unique claim.
From Immunity Support to Weight loss, Omega 3 Heart Health, Detox, Energy, Sleep, Joint Support, Bone Health, Daily Vitamins and even Hangover prevention, we have created a wide variety of hot product segments for the large and growing nutrition industry and are poised for significant growth.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the ability of the Company to reach its expansion goals and generate exciting new developments. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov .
IR Contact:
